Skip to content
Search

Latest Stories

Submit Guest Post

Climate change could increase child stunting in south Asia by 2050, a study finds

Heat and humidity during pregnancy threaten child development across world's most densely populated region

Climate change could increase child stunting in south Asia by 2050, a study finds

Researchers at the University of California Santa Barbara examined how exposure to extremely climate conditions during pregnancy impacts children's health

iStock - Representative image

Highlights

  • Over 3 million additional cases of stunting projected in south Asian children by 2050 due to climate change.
  • Hot-humid conditions four times more harmful than heat alone during pregnancy's third trimester.
  • Early and late pregnancy stages identified as most vulnerable periods for foetal development.

Climate change-driven heat and humidity could lead to more than three million additional cases of stunting among south Asia's children by 2050, according to a new study that highlights the severe health risks facing the world's most densely populated region.

Researchers at the University of California Santa Barbara examined how exposure to extremely hot and humid conditions during pregnancy impacts children's health, focusing on height-for-age measurements, a key indicator of chronic health status in children under five.


The findings, published in the journal Science, reveal that humidity significantly worsens the effects of heat exposure, partly because it prevents pregnant women from cooling down effectively.

Pregnant women are particularly susceptible to heat stress due to additional weight and hormonal changes that make them vulnerable to overheating.

"At the beginning of pregnancy, the foetus is very vulnerable, while at the end of pregnancy, the mother is more vulnerable," explained lead author Katie McMahon, a doctoral student at the university.

The research identified early and late pregnancy as the most critical periods, with the third trimester showing particularly alarming results.

Professor Kathy Baylis from the university's geography department noted that health outcomes from heat and humidity exposure during this period were approximately four times worse than those from heat alone.

Stunting future impact

The study utilised wet-bulb globe temperature measurements, which account for humidity, radiant heat and airflow beyond standard air temperature readings.

Researchers discovered that each additional day with maximum wet-bulb globe temperature exceeding 29 degrees Celsius was associated with reduced live births six to 12 months later.

Conversely, each extra day above 35 degrees Celsius correlated with increased birth rates within three months of exposure, suggesting hotter temperatures may be shifting births earlier while hot-humid conditions could be reducing conception rates or increasing early-stage pregnancy loss.

"Exposure to hot, humid conditions in-utero is dangerous for child health, and more dangerous than just hot temperatures alone," McMahon warned.

South Asia is projected to be among the world's worst affected regions as hot and humid conditions intensify under continued global warming.

The researchers cautioned that by focusing solely on temperature effects, health professionals may be underestimating the true impact of extreme weather on maternal and child health.

The study drew child health data from Demographic and Health Surveys, with weather data provided by the Climate Hazards Centre at the University of California Santa Barbara.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

cancer treatment

The NHS availability announced in September 2026 applies to eligible patients in England. The treatment has already been available in Scotland for more than two years.

What is Enhertu and how could the new NHS breast cancer treatment help patients?

Highlights:
  • Enhertu is a targeted treatment for certain HER2-low breast cancers.
  • It is available for around 1,000 women in England.
  • The drug can extend survival compared with chemotherapy.
  • NICE initially rejected widespread NHS use in 2024.
  • The decision was reversed after a commercial agreement was reached.

Breast cancer treatment continues to evolve as researchers develop therapies aimed at specific characteristics of cancer cells. One such treatment is Enhertu, which has now become available on the NHS in England for people with a particular type of advanced breast cancer.

The treatment is intended for patients with HER2-low breast cancer that cannot be removed through surgery or has spread to other parts of the body. This is known as metastatic breast cancer. According to the latest announcement, around 1,000 women in England will be eligible for the treatment.

Keep ReadingShow less